Cosciens Biopharma Inc
(CSCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-1992 | 05-1992 | 02-1992 | 08-1991 | 08-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 918 | N/A | N/A | 1,178 | 1,211 |
| Depreciation Amortization | 482 | N/A | N/A | 501 | 405 |
| Other Working Capital | -4,251 | N/A | N/A | 586 | -1,204 |
| Other Operating Activity | 390 | 0 | 0 | -237 | 308 |
| Operating Cash Flow | $-2,461 | $N/A | $N/A | $2,028 | $720 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -565 | N/A | N/A | -491 | -649 |
| Net Acquisitions | -245 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-810 | $N/A | $N/A | $-491 | $-649 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | N/A | -195 | -240 |
| Other Financing Activity | 3,973 | 0 | 0 | -1,224 | 216 |
| Financing Cash Flow | $3,973 | $N/A | $N/A | $-1,419 | $-24 |
| Beginning Cash Position | 452 | N/A | N/A | 95 | 48 |
| End Cash Position | 1,154 | N/A | N/A | 213 | 95 |
| Net Cash Flow | $702 | $N/A | $N/A | $118 | $47 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,461 | N/A | N/A | 2,028 | 720 |
| Free Cash Flow | -2,461 | 0 | 0 | 2,028 | 720 |